Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS patients

Maria Assunta Piano, Lisa Gianesello, Angela Grassi, Paola Del Bianco, Adriana Mattiolo, Anna Maria Cattelan, Lolita Sasset, Paola Zanovello, Maria Luisa Calabrò

Research output: Contribution to journalArticle

Abstract

The aim of this study was to identify circulating microRNAs (miRNAs) that could be used as biomarkers in patients at risk for or affected by AIDS-Kaposi's sarcoma (KS). Screening of 377 miRNAs was performed using low-density arrays in pooled plasma samples of 10 HIV/human herpesvirus 8 (HHV8)-infected asymptomatic and 10 AIDS-KS patients before and after successful combined antiretroviral therapy (cART). MiR-375 was identified as a potential marker of active KS, being the most down-regulated in AIDS-KS patients after cART and the most up-regulated in naïve AIDS-KS patients compared to naïve asymptomatic subjects. Validation on individual plasma samples confirmed that miR-375 levels were higher in AIDS-KS compared to asymptomatic patients, decreased after cART-induced remission in most AIDS-KS patients and increased in patients with active KS. In asymptomatic patients miR-375 was up-regulated after cART in both screening and validation. Statistical analyses revealed an association between miR-375 changes and CD4 cell counts, which could explain the discordant cases and the opposite trend between asymptomatic and AIDS-KS patients. These data suggest that circulating miR-375 might be a good indicator of active AIDS-KS. Moreover, changes in miR-375 levels may have a prognostic value in HIV/HHV8-infected patients undergoing treatment. Further large-scale validation is needed.

Original languageEnglish
Number of pages9
JournalJournal of Cellular and Molecular Medicine
DOIs
Publication statusAccepted/In press - Dec 13 2018

Fingerprint

Kaposi's Sarcoma
MicroRNAs
Acquired Immunodeficiency Syndrome
Biomarkers
Human Herpesvirus 8
HIV
Therapeutics
CD4 Lymphocyte Count

Keywords

  • biomarker
  • circulating miRNA
  • HHV8
  • HIV
  • Kaposi’s sarcoma
  • microRNA
  • miR-375

ASJC Scopus subject areas

  • Molecular Medicine
  • Cell Biology

Cite this

@article{42684972d99c436ab149f28947ae75a8,
title = "Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS patients",
abstract = "The aim of this study was to identify circulating microRNAs (miRNAs) that could be used as biomarkers in patients at risk for or affected by AIDS-Kaposi's sarcoma (KS). Screening of 377 miRNAs was performed using low-density arrays in pooled plasma samples of 10 HIV/human herpesvirus 8 (HHV8)-infected asymptomatic and 10 AIDS-KS patients before and after successful combined antiretroviral therapy (cART). MiR-375 was identified as a potential marker of active KS, being the most down-regulated in AIDS-KS patients after cART and the most up-regulated in na{\"i}ve AIDS-KS patients compared to na{\"i}ve asymptomatic subjects. Validation on individual plasma samples confirmed that miR-375 levels were higher in AIDS-KS compared to asymptomatic patients, decreased after cART-induced remission in most AIDS-KS patients and increased in patients with active KS. In asymptomatic patients miR-375 was up-regulated after cART in both screening and validation. Statistical analyses revealed an association between miR-375 changes and CD4 cell counts, which could explain the discordant cases and the opposite trend between asymptomatic and AIDS-KS patients. These data suggest that circulating miR-375 might be a good indicator of active AIDS-KS. Moreover, changes in miR-375 levels may have a prognostic value in HIV/HHV8-infected patients undergoing treatment. Further large-scale validation is needed.",
keywords = "biomarker, circulating miRNA, HHV8, HIV, Kaposi’s sarcoma, microRNA, miR-375",
author = "Piano, {Maria Assunta} and Lisa Gianesello and Angela Grassi and {Del Bianco}, Paola and Adriana Mattiolo and Cattelan, {Anna Maria} and Lolita Sasset and Paola Zanovello and Calabr{\`o}, {Maria Luisa}",
year = "2018",
month = "12",
day = "13",
doi = "10.1111/jcmm.14054",
language = "English",
journal = "Journal of Cellular and Molecular Medicine",
issn = "1582-1838",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Circulating miRNA-375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS patients

AU - Piano, Maria Assunta

AU - Gianesello, Lisa

AU - Grassi, Angela

AU - Del Bianco, Paola

AU - Mattiolo, Adriana

AU - Cattelan, Anna Maria

AU - Sasset, Lolita

AU - Zanovello, Paola

AU - Calabrò, Maria Luisa

PY - 2018/12/13

Y1 - 2018/12/13

N2 - The aim of this study was to identify circulating microRNAs (miRNAs) that could be used as biomarkers in patients at risk for or affected by AIDS-Kaposi's sarcoma (KS). Screening of 377 miRNAs was performed using low-density arrays in pooled plasma samples of 10 HIV/human herpesvirus 8 (HHV8)-infected asymptomatic and 10 AIDS-KS patients before and after successful combined antiretroviral therapy (cART). MiR-375 was identified as a potential marker of active KS, being the most down-regulated in AIDS-KS patients after cART and the most up-regulated in naïve AIDS-KS patients compared to naïve asymptomatic subjects. Validation on individual plasma samples confirmed that miR-375 levels were higher in AIDS-KS compared to asymptomatic patients, decreased after cART-induced remission in most AIDS-KS patients and increased in patients with active KS. In asymptomatic patients miR-375 was up-regulated after cART in both screening and validation. Statistical analyses revealed an association between miR-375 changes and CD4 cell counts, which could explain the discordant cases and the opposite trend between asymptomatic and AIDS-KS patients. These data suggest that circulating miR-375 might be a good indicator of active AIDS-KS. Moreover, changes in miR-375 levels may have a prognostic value in HIV/HHV8-infected patients undergoing treatment. Further large-scale validation is needed.

AB - The aim of this study was to identify circulating microRNAs (miRNAs) that could be used as biomarkers in patients at risk for or affected by AIDS-Kaposi's sarcoma (KS). Screening of 377 miRNAs was performed using low-density arrays in pooled plasma samples of 10 HIV/human herpesvirus 8 (HHV8)-infected asymptomatic and 10 AIDS-KS patients before and after successful combined antiretroviral therapy (cART). MiR-375 was identified as a potential marker of active KS, being the most down-regulated in AIDS-KS patients after cART and the most up-regulated in naïve AIDS-KS patients compared to naïve asymptomatic subjects. Validation on individual plasma samples confirmed that miR-375 levels were higher in AIDS-KS compared to asymptomatic patients, decreased after cART-induced remission in most AIDS-KS patients and increased in patients with active KS. In asymptomatic patients miR-375 was up-regulated after cART in both screening and validation. Statistical analyses revealed an association between miR-375 changes and CD4 cell counts, which could explain the discordant cases and the opposite trend between asymptomatic and AIDS-KS patients. These data suggest that circulating miR-375 might be a good indicator of active AIDS-KS. Moreover, changes in miR-375 levels may have a prognostic value in HIV/HHV8-infected patients undergoing treatment. Further large-scale validation is needed.

KW - biomarker

KW - circulating miRNA

KW - HHV8

KW - HIV

KW - Kaposi’s sarcoma

KW - microRNA

KW - miR-375

UR - http://www.scopus.com/inward/record.url?scp=85058422052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058422052&partnerID=8YFLogxK

U2 - 10.1111/jcmm.14054

DO - 10.1111/jcmm.14054

M3 - Article

AN - SCOPUS:85058422052

JO - Journal of Cellular and Molecular Medicine

JF - Journal of Cellular and Molecular Medicine

SN - 1582-1838

ER -